Danish biotech prepares defence against allegations of trade secret misappropriation | AbbVie claims two former employees ...

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

Supplementary Protection Certificate rules interpreted in different ways have left the EU’s generic and biosimilar industries hungry for clarity, explains Jiri Slavik of Adalvo. If you don't have a ...

Trio files multiple patent infringement lawsuits to protect blockbuster prostate cancer drug | Latest suits target Hetero and ...

New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial ...

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

John Squires’ IP monetisation history offers clues to his interests, but supporters say his focus on business and innovation ...

21 January 2025 New president says repeal is first of “many steps the US federal government will take to repair our ...

As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa ...

13 June 2024 Biotech takes legal action against Tempus AI, alleging patent infringement in Tempus's liquid biopsy products | Complaint accuses Tempus of unauthorised use of Guardant's tech crucial for ...

The ex-Cadwell Clonts Reeder & Thomas trial attorney and litigator represents clients in all phases of litigation in both federal and state courts, bringing particular experience of disputes in the ...